跳至主要内容
临床试验/NCT03816475
NCT03816475Unknown2 期

Hypofractionated 5x5 Gy Radiotherapy With Prolonged Gap Before Surgery in Preoperative Treatment of Patients With Locally Advanced Myxoid Liposarcomas of Extremities or Trunk Wall

Maria Sklodowska-Curie National Research Institute of Oncology2 个研究点 分布在 1 个国家目标入组 35 人开始时间: 2015年4月24日最近更新:
适应症
干预措施

试验速览

阶段
2 期
入组人数
35
试验地点
2
主要终点
Wound complication rate

研究概览

简要总结

After a screening, which consists of pathology confirmation, physical examination, magnetic resonance imaging (MRI), body computed tomography (CT) scan, blood tests, and case analysis on Multidisciplinary Team (MDT) meeting, patient will be irradiated 5x5 Gy and after radiotherapy and then referred for surgery 6-8 weeks after the radiotherapy completion.

详细描述

Myxoid liposarcoma has been reported to be more radiosensitive compared with other soft tissue sarcomas (STS). Response to preoperative treatment involves in decrease in tumor size, a large percentage in tumor necrosis (which according to some reports has a beneficial effect on the reduction of local recurrence rates) and also among other in a change in vasculature of the tissue.

Hypofractionation represents a variation of radiotherapy fractionation in which the total dose is divided into fewer fractions with an increased fraction dose. Such treatment may lead to additional biological effects when compared to conventionally fractionated radiotherapy (eg. vascular damage, increased immunogenicity, and antigenicity). The main advantages of hypofractionation are those related to the decreased overall treatment time what is more convenient for both patients and physicians, increased compliance and makes the treatment more cost-effective. Intriguing, such an approach may provide an additional benefit when treating non-radiosensitive tumors with a low alpha/beta ratio (eg. sarcomas).

The use of preoperative hypofractionated radiotherapy 5x5 Gy for five consecutive days, and then immediate surgery in patients with locally advanced soft tissue sarcomas showed in a published study a good local control rate, with a favorable amount of late toxicities. In this patient population, there were 22 patients with primary myxoid liposarcoma and the local control rate in this group was 86%.

In the proposed study we plan to increase the gap between the end of radiotherapy and surgery to commonly applied five weeks to better assess the changes occurring in the tumor after treatment and to evaluate the impact of longer treatment interval on reducing the proportion of early complications of treatment.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • ≥ 18 years old;
  • Eastern Cooperative Oncology Group (ECOG) performance status 0 - 2;
  • pathologically confirmed diagnosis of localized, potentially resectable myxoid liposarcoma;
  • primary tumor without previous treatment;
  • extremity or trunk wall localization of the tumor;
  • eligibility for limb-sparing surgery;
  • >= 5cm in the longest diameter at imaging staging (MRI);
  • adequate hematologic, liver, and renal function;
  • women of childbearing potential must have a negative pregnancy test on the day of registration for study;
  • female subjects who are breastfeeding should discontinue nursing prior to the first day of study treatment and during the whole radiotherapy treatment;
  • no co-existing malignancy within the last 2 years except for adequately treated basal cell carcinoma of the skin or carcinoma in situ of the cervix;
  • the absence of any psychological, familial, sociological or geographical condition potentially hampering compliance with the study protocol and follow-up schedule; those conditions should be discussed with the patient before randomization in the trial;
  • before patient randomization, written informed consent must be given according to ICH/GCP.

排除标准

  • history of radiation to the affected volume;
  • previous or planned neoadjuvant chemotherapy;
  • contraindications to radiotherapy, or surgery;
  • metastatic disease.

研究组 & 干预措施

Hypofractionated radiotherapy

Experimental

5x5 Gy radiotherapy and delayed surgery (after 6-8 weeks)

干预措施: Hypofractionated radiotherapy (Radiation)

结局指标

主要结局

Wound complication rate

时间窗: 6 months

Wound complication rate

次要结局

  • Percentage of tumor necrosis(2 months)
  • Local control rate(60 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Unknown
2 期
Hypofractionated Radiotherapy With Sequential Chemotherapy in Marginally Resectable Soft Tissue Sarcomas of Extremities or Trunk WallFibrosarcomaMyosarcomaHistiocytic SarcomaLymphangiosarcomaMalignant Peripheral Nerve Sheath TumorsLiposarcomaMyxoid LiposarcomaUndifferentiated SarcomaPleomorphic LiposarcomaUndifferentiated Pleomorphic SarcomaDedifferentiated LiposarcomaPleomorphic RhabdomyosarcomaMalignant Triton TumorSarcomaLeiomyosarcomaMyxofibrosarcomaSynovial Sarcoma
NCT03651375Maria Sklodowska-Curie National Research Institute of Oncology46
Unknown
2 期
Hypofractionated Radiotherapy With Hyperthermia in Unresectable or Marginally Resectable Soft Tissue SarcomasClear Cell SarcomaMalignant Peripheral Nerve Sheath TumorsMyxoid LiposarcomaLiposarcoma, DedifferentiatedSarcomaUndifferentiated Pleomorphic SarcomaFibrosarcomaPleomorphic RhabdomyosarcomaLeiomyosarcomaSynovial SarcomaAlveolar Soft Part Sarcoma
NCT03989596Maria Sklodowska-Curie National Research Institute of Oncology30
已完成
不适用
Radiotherapy With Hyperthermia in Recurrent and Radiation-Induced SarcomasRadiation Induced NeoplasmsRadiation-Induced CancerRecurrent SarcomaRecurrent Soft Tissue Sarcoma
NCT04398095Maria Sklodowska-Curie National Research Institute of Oncology20
已完成
2 期
Palliative Radiotherapy Protocol in Head and Neck CancerHead and Neck NeoplasmsQuality of Life
NCT02460471Maisonneuve-Rosemont Hospital32
已完成
2 期
Shorter Course Radiation for the Treatment of Breast Cancer That Has Spread to Lymph NodesBreast Cancer
NCT02700386University of Colorado, Denver108